Literature DB >> 30868381

Moral hazard under zero price policy: evidence from Japanese long-term care claims data.

Rong Fu1, Haruko Noguchi2.   

Abstract

We evaluate the presence and magnitude of moral hazard in Japan's public long-term care insurance (LTCI) market. Using monthly LTCI claim records from January 2006 to December 2015 linked to concurrent death records, we construct a sample by propensity score matching insured individuals who co-pay 10% of their fees to those with no required copayments, and we implement fixed-effect estimations. We find that a ten-percentage-point reduction in the copayment rate increases monthly costs by 10.2 thousand yen, corresponding to a price elasticity of about - 0.1. Insured individuals with no copayments tend to use more services and have more utilization days than those with copayments do. Furthermore, we find that insured individuals who die from cerebral (myocardial) infarction increase their service use more in response to a reduction in the copayment rate than those who die from senility do, indicating a positive association between ex-ante health risks and ex-post service use. We verify that a cost-sharing adjustment is a valid solution for soaring LTCI expenditures. These findings could provide broad implications for the rapidly aging world.

Entities:  

Keywords:  Ex-ante health risk; Japan; Moral hazard; Propensity score matching; Public long-term care insurance

Mesh:

Year:  2019        PMID: 30868381     DOI: 10.1007/s10198-019-01041-6

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  3 in total

Review 1.  The use of Japanese long-term care insurance claims in health services research: current status and perspectives.

Authors:  Xueying Jin; Nanako Tamiya
Journal:  Glob Health Med       Date:  2021-06-30

2.  Healthcare Utilization Under a Comprehensive Public Welfare Program: Evidence From Japan.

Authors:  Michio Yuda
Journal:  Front Public Health       Date:  2022-06-23

3.  Age Structural Transitions and Copayment Policy Effectiveness: Evidence from Taiwan's National Health Insurance System.

Authors:  Ya-Ling Lin; Wen-Yi Chen; Shwn-Huey Shieh
Journal:  Int J Environ Res Public Health       Date:  2020-06-12       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.